Insider Purchases: Inside the Buy

Tag: Dividend aristocrat

FUNanc1al-style scene showing a massive medieval stone castle perched atop a mountain of insurance policies. Instead of defending against dragons, the castle collects golden fee coins flowing through pipelines from homeowners, cars, and businesses below.

🦅 Erie Indemnity (ERIE): The Hidden Fee Castle Behind an 11-Day Short Squeeze Setup

Erie Indemnity isn't a traditional insurer. It collects fees rather than assuming most underwriting risk, creating one of the most unique business models in financial services. After a rare $1.4 million insider purchase, a 59% decline from all-time highs, and nearly 12 days-to-cover short interest, investors may want another look at this Dividend Aristocrat.

Read entire article

Tags: buy or sell ERIE, CapitalLight, CarpeDiem, compounders, dividend aristocrat, dividend growth investing, dividend investing, DividendAristocrat, ERIE, erie indemnity, erie insurance, erie stock, ErieIndemnity, financial stocks, fred marsanne, funanc1al, insider buying, InsiderBuying, insurance industry, insurance stocks, InsuranceBrokers, nasdaq erie, passive income, quality stocks, risks buying ERIE, short squeeze stocks, ShortSqueeze, stock analysis, value investing, ValueInvesting, why buy ERIE
Illustration of Kimberly-Clark brands (tissues and diapers) alongside a Band-Aid and pill bottle, symbolizing KMB’s shift toward health and personal care while highlighting its high dividend yield.

Band-Aids & Bottom Lines: Why Kimberly-Clark’s 5% Yield Is the Ultimate Turnaround Play

KMB isn’t flashy—but it might be one of 2026’s sneakiest high-yield turnarounds. A $1M insider buy, heavy institutional ownership, and a big strategic pivot (hello, Tylenol & Band-Aids via Kenvue) have the market nervous… and contrarians intrigued.

Read entire article

Tags: buy or sell kmb, Consumer Staples, contrarian investment, contrarian play, Defensive Stocks, director buying, Dividend aristocrat, Dividend Stocks, featured-insiders, funanc1al edge, funanc1al investing, Healthcare & Personal Care, hub-insiders, Income Investing, Insider Buying, kenvue, Kimberly-Clark, KMB, merger, Risks buying KMB, share buyback, Todd Maclin, turnaround play, Turnaround Stories, Value Investing, why buy KMB